全球基于 PCR 的移植诊断市场，按测试类型（CMV PCR 测试、EBV PCR 测试、BKV PCR 测试、VZV PCR 测试、HSV1 PCR 测试、HSV2 PCR 测试、细小病毒 B19 PCR 测试、P. Jirovecii PCR 测试、JCV PCR 测试、腺病毒 PCR 测试和曲霉菌 PCR 测试）、移植类型（肾移植、肝移植、心脏移植、肺移植、胰腺移植和其他移植）、应用（诊断应用和研究应用）、最终用户（医院和移植中心、商业服务提供商、研究实验室和学术机构）划分 - 行业趋势和预测到 2031 年。
基于 PCR 的移植诊断市场分析和见解
推动市场增长的主要因素之一是器官衰竭患病率的上升。此外，全球范围内非侵入性诊断方法的日益普及是推动市场增长的另一个关键因素。器官保存技术的进步也影响着市场。然而，缺乏具有移植诊断专业知识的专业人员正在制约市场的增长。
另一方面，市场参与者的战略启动和技术发布为市场增长提供了机会。然而，器官移植过程中面临的伦理挑战可能会对市场增长造成挑战。
Data Bridge Market Research 分析称，预计到 2031 年市场规模将从 2023 年的 612,500.00 万美元增至 995,007.52 万美元，在 2024 年至 2031 年的预测期内，复合年增长率为 6.5%。
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（千美元） |
|
涵盖的领域 |
检测类型（CMV PCR 检测、EBV PCR 检测、BKV PCR 检测、VZV PCR 检测、HSV1 PCR 检测、HSV2 PCR 检测、细小病毒 B19 PCR 检测、P. Jirovecii PCR 检测、JCV PCR 检测、腺病毒 PCR 检测和曲霉菌属 PCR 检测）、移植类型（肾移植、肝移植、心脏移植、肺移植、胰腺移植和其他移植）、应用（诊断应用和研究应用）、最终用户（医院和移植中心、商业服务提供商、研究实验室和学术机构） |
|
覆盖国家 |
美国、加拿大、墨西哥、德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士、欧洲其他地区、中国、日本、印度、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲其他地区 |
|
涵盖的市场参与者 |
Quest Diagnostics Incorporated、Laboratory Corporation of America Holdings、Eurofins Viracor, LLC、Sonic Healthcare USA、Ambar Lab、ARUP Laboratories 和 Dr. Lal PathLabs 等 |
市场定义
PCR 是一种分子生物学技术，用于扩增特定的 DNA 序列，能够以高精度和高灵敏度检测和分析遗传物质。在移植诊断方面，基于 PCR 的检测用于评估器官捐赠者和接受者之间的兼容性、监测移植后结果以及检测排斥或并发症的迹象。该市场可以定义为医疗保健行业的一部分，专注于在器官移植程序中利用 PCR 技术进行诊断。
全球基于 PCR 的移植诊断市场动态
本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容：
驱动程序
- 器官衰竭患病率不断上升
随着器官衰竭的发生率不断上升，为了挽救生命和改善患者的生活质量，对器官移植的需求也日益增长。肾脏、肝脏、心脏和肺脏等器官可能由于各种原因而衰竭，包括慢性疾病、遗传疾病或创伤。慢性疾病（如慢性肾病、肝病和心脏病）的患病率不断上升，导致需要器官移植的患者数量不断增加。这些患者通常需要进行移植诊断，以确保供体器官和接受者的兼容性，从而最大限度地降低排斥风险。因此，器官衰竭的患病率不断上升正在推动市场增长。
- 非侵入性诊断方法日益普及
非侵入性诊断方法（例如血液检测和成像技术）消除了对组织活检等侵入性程序的需求。这提高了患者的舒适度，从而提高了诊断评估的接受度和依从性。在移植诊断方面，非侵入性方法提供了一种侵入性较小的方法来评估供体和受体之间的兼容性。侵入性诊断程序（例如组织活检）具有固有的并发症风险，包括出血和感染。非侵入性方法风险较低，对患者和医疗保健提供者都有吸引力。对于可能已经免疫功能低下的移植患者来说，并发症风险的降低尤其重要。因此，非侵入性诊断方法的日益普及正在推动市场增长。
机会
- 市场参与者的战略启动和技术发布
受捐献器官需求增加的推动，基于 PCR 的移植诊断市场不断增长，这强调了合作伙伴关系、业务扩展和发展努力等战略举措。这些举措以深思熟虑的战略为指导，包括引入移植诊断试剂盒，例如曲霉菌 PCR 检测、PCR 检测、CMV PCR 检测、EBV PCR 检测、BKV PCR 检测和 VZV PCR 检测。实施这些战略框架使市场参与者能够协调其组织活动，提高运营效率并使工作与移植诊断的动态格局保持一致。
因此，市场参与者的这些战略举措有望成为市场增长的机遇。
限制/挑战
- 移植诊断专业人才短缺
缺乏熟练的专业人员可能导致无法获得专业的移植诊断服务。这对于缺乏训练有素的人员地区的医疗机构来说尤其具有挑战性，导致器官移植程序的诊断支持延迟或不足。移植诊断专家的短缺可能会影响诊断评估的质量和准确性。缺乏专业知识和经验可能会导致对测试结果的解释出现错误，从而可能影响器官移植的成功率。
这也可能影响移植诊断的研究和开发工作。专业知识不足可能会减缓创新步伐，阻碍新诊断技术和方法的开发，从而限制市场增长
- 器官移植面临的伦理挑战
重要器官衰竭发生率不断上升，再加上器官供应不足，导致器官需求不断增长，而器官供应却有限，两者之间存在巨大差距。这一关键问题不仅延长了器官接受者的审批时间，还导致死亡率上升。在应对这一紧迫挑战时，基于 PCR 的诊断测试发挥着关键作用，有助于确保器官移植的兼容性和可行性。HLA 分型 PCR 测试和巨细胞病毒 (CMV) PCR 测试等测试有助于确定捐赠者和接受者之间的兼容性，有助于高效分配器官并缩短审批时间。
因此，显然器官移植过程中面临的伦理挑战预计将对市场增长构成挑战。
最新动态
- 2024 年 1 月，Laboratory Corporation of America Holdings 推出了一项针对孕妇先兆子痫的新检测，这代表了孕产妇保健领域的重大进步。借助这种先进的诊断工具，医疗保健提供者可以在怀孕早期识别出患严重先兆子痫风险较高的女性。这使该公司能够进行更警惕的监测和主动的医疗干预，从而有可能降低并发症风险并改善孕产妇和胎儿的结果
- 2023 年 9 月，Sonic Healthcare 收购了 Healius Ltd.，以促进澳大利亚医疗保健领域的发展。此次收购进一步巩固了 Sonic 作为病理学全球领导者的地位，增强了其相对于其他国际参与者的竞争优势。这表明该公司致力于在行业内扩张和整合，可能为其他地区的类似合并铺平道路
- 2023 年 10 月，Sonic Healthcare 投资了人工智能病理学公司 PaigeAI，彰显了他们致力于利用尖端技术提高病理学领域的诊断准确性和效率。此举对医学诊断的未来具有重要意义。这种精准方法可以带来更有效的治疗，并可能降低不必要药物副作用的风险
- 2020 年 8 月，Eurofins Viracor 与北美实体器官移植医学领域的领导者西北大学综合移植中心合作，开展了高影响力的研究及其临床培训计划。此次研究合作进一步验证了 Eurofins 最近收购 Transplant Genomics Inc. (“TGI”) 及其血液基因表达测试 TruGraf 所获得的新型测试。TruGraf 可以排除肾功能稳定的肾移植患者的“无症状”亚临床肾排斥反应。TGI 最近通过 Palmetto GBA 的分子诊断服务 (MolDX) 计划从医疗保险和医疗补助服务中心 (CMS) 收到了当地覆盖范围确定 (LCD) 决定草案。这有助于该公司验证其研究
- 2020 年 6 月，Transplant Genomics, Inc. 和 Eurofins Viracor 宣布成立 Eurofins 移植医学和科学顾问委员会，利用移植和技术开发方面的各种专业知识和理解，提高整个移植社区诊断的临床价值。董事会成员专注于改进和产品开发，利用他们独特的视角帮助 TGI 和 Viracor 扩大规模，以满足移植领域未满足的需求并指导未来的产品。这有助于公司扩大其产品组合
全球基于 PCR 的移植诊断市场范围
全球 PCR 移植诊断市场根据检测类型、移植类型、应用和最终用户分为四个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
测试类型
- CMV PCR 检测
- EBV PCR 检测
- BKV PCR 检测
- 水痘带状疱疹病毒 PCR 检测
- HSV1 PCR 检测
- HSV2 PCR 检测
- 细小病毒 B19 PCR 检测
- P. Jirovecii PCR 检测
- JCV PCR 检测
- 腺病毒 PCR 检测
- 曲霉菌 PCR 检测
根据测试类型，全球基于 PCR 的移植诊断市场细分为 CMV PCR 测试、EBV PCR 测试、BKV PCR 测试、VZV PCR 测试、HSV1 PCR 测试、HSV2 PCR 测试、细小病毒 B19 PCR 测试、P. Jirovecii PCR 测试、JCV PCR 测试、腺病毒 PCR 测试和曲霉菌 PCR 测试。
移植类型
- 肾移植
- 肝移植
- 心脏移植
- 肺移植
- 胰腺移植
- 其他移植
根据移植类型，全球基于 PCR 的移植诊断市场分为肾移植、肝移植、心脏移植、肺移植、胰腺移植和其他移植。
应用
- 诊断应用
- 研究应用
根据应用，全球基于 PCR 的移植诊断市场分为诊断应用和研究应用。
最终用户
- 医院和移植中心
- 商业服务提供商
- 研究实验室和学术机构
根据最终用户，全球基于 PCR 的移植诊断市场分为医院和移植中心、商业服务提供商以及研究实验室和学术机构。
全球基于 PCR 的移植诊断市场区域分析/见解
全球基于 PCR 的移植诊断市场根据测试类型、移植类型、应用和最终用户分为四个显著的部分。
本市场报告涵盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士、欧洲其他地区、中国、日本、印度、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲其他地区。
由于主要市场参与者的存在和技术进步，北美有望在市场中占据主导地位。由于美国对器官移植的需求不断增长，预计美国将在北美地区占据主导地位。由于德国对基于 PCR（聚合酶链反应）的移植诊断应用的认识不断提高，预计德国将在欧洲地区占据主导地位。由于中国肾衰竭发病率不断上升，预计中国将在亚太地区占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，以及销售渠道的影响。
全球基于 PCR 的移植诊断市场份额分析和竞争格局
全球 PCR 移植诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用优势、产品类型生命线曲线。以上提供的数据点仅与公司对全球 PCR 移植诊断市场的关注有关。
市场上的一些主要参与者包括 Quest Diagnostics Incorporated、Laboratory Corporation of America Holdings、Eurofins Viracor, LLC、Sonic Healthcare USA、Ambar Lab、ARUP Laboratories 和 Dr. Lal PathLabs 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TEST TYPE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF ORGAN FAILURE
5.1.2 RISING POPULARITY OF NON-INVASIVE DIAGNOSTIC METHODS
5.1.3 ADVANCEMENT IN ORGAN PRESERVATIVE TECHNIQUES
5.1.4 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
5.2 RESTRAINTS
5.2.1 SHORTAGE OF PROFESSIONALS WITH EXPERTISE IN TRANSPLANT DIAGNOSTICS
5.2.2 HIGH COST OF PCR/NGS SOFTWARE
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATION AND TECHNOLOGY LAUNCHES BY MARKET PLAYERS
5.3.2 RISE IN GOVERNMENT SUPPORT AND FUNDING FOR PCR-BASED ORGAN TRANSPLANTATION
5.3.3 SURGE OF AWARENESS FOR ORGAN TRANSPLANTATION
5.4 CHALLENGES
5.4.1 ETHICAL CHALLENGES FACED DURING ORGAN TRANSPLANTATION
5.4.2 LACK OF ORGAN DONORS AND PROVIDERS ANNUALLY
6 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE
6.1 OVERVIEW
6.2 CMV PCR TEST
6.3 EBV PCR TEST
6.4 BKV PCR TEST
6.5 VZV PCR TEST
6.6 HSV1 PCR TEST
6.7 HSV2 PCR TEST
6.8 PARVOVIRUS B19 PCR TEST
6.9 P. JIROVECII PCR TEST
6.1 JCV PCR TEST
6.11 ADENOVIRUS PCR TEST
6.12 ASPERGILLUS SPP PCR TEST
7 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE
7.1 OVERVIEW
7.2 KIDNEY TRANSPLANTATION
7.3 LIVER TRANSPLANTATION
7.4 HEART TRANSPLANTATION
7.5 LUNG TRANSPLANTATION
7.6 PANCREAS TRANSPLANTATION
7.7 OTHER TRANSPLANTATIONS
8 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 DIAGNOSTIC APPLICATIONS
8.3 RESEARCH APPLICATIONS
9 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS AND TRANSPLANT CENTERS
9.3 COMMERCIAL SERVICE PROVIDERS
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
10 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 FRANCE
10.3.2 U.K.
10.3.3 SPAIN
10.3.4 GERMANY
10.3.5 TURKEY
10.3.6 ITALY
10.3.7 RUSSIA
10.3.8 NETHERLANDS
10.3.9 BELGIUM
10.3.10 SWITZERLAND
10.3.11 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 SOUTH KOREA
10.4.4 AUSTRALIA
10.4.5 JAPAN
10.4.6 THAILAND
10.4.7 PHILIPPINES
10.4.8 INDONESIA
10.4.9 MALAYSIA
10.4.10 SINGAPORE
10.4.11 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
10.5.1 BRAZIL
10.5.2 ARGENTINA
10.5.3 REST OF SOUTH AMERICA
10.6 MIDDLE EAST AND AFRICA
10.6.1 SAUDI ARABIA
10.6.2 ISRAEL
10.6.3 EGYPT
10.6.4 SOUTH AFRICA
10.6.5 U.A.E.
10.6.6 REST OF MIDDLE EAST AND AFRICA
11 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 SWOT ANALYSIS
13 COMPANY PROFILES
13.1 QUEST DIAGNOSTICS INCORPORATED.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 LABORATORY CORPORATION OF AMERICA HOLDINGS.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENT
13.3 EUROFINS VIRACOR
13.3.1 COMPANY SNAPSHOT
13.3.2 COMPANY SHARE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENTS
13.4 SONIC HEALTHCARE LIMITED
13.4.1 COMPANY SNAPSHOT
13.4.2 PRODUCT REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 DR LAL PATHLABS.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 ARUP LABORATORIES
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 AMBAR LAB.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
表格列表
TABLE 1 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 2 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 3 GLOBAL CMV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 4 GLOBAL EBV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 5 GLOBAL BKV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 6 GLOBAL VZV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 7 GLOBAL HSV1 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 8 GLOBAL HSV2 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 9 GLOBAL PARVOVIRUS B19 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 10 GLOBAL P. JIROVECII PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 11 GLOBAL JCV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 12 GLOBAL ADENOVIRUS PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 13 GLOBAL ASPERGILLUS SPP PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 14 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 15 GLOBAL KIDNEY TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 16 GLOBAL LIVER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 GLOBAL HEART TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 18 GLOBAL LUNG TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 GLOBAL PANCREAS TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 GLOBAL OTHER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 22 GLOBAL DIAGNOSTIC APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 23 GLOBAL RESEARCH APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 24 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 25 GLOBAL HOSPITALS AND TRANSPLANT CENTERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 26 GLOBAL COMMERCIAL SERVICE PROVIDERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 27 GLOBAL RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 30 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 31 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 32 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 33 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 34 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 35 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 36 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 37 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 38 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 39 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 40 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 41 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 42 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 43 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 44 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 45 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 46 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 47 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 48 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 49 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 50 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 51 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 52 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 53 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 54 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 55 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 56 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 58 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 60 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 61 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 63 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 64 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 65 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 66 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 67 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 68 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 70 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 71 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 73 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 75 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 76 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 78 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 79 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 80 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 81 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 83 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 85 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 86 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 88 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 89 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 90 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 91 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 92 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 93 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 95 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 96 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 98 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 100 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 101 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 102 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 103 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 104 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 105 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 106 REST OF EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 REST OF EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 108 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 109 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 111 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 112 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 113 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 114 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 115 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 116 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 118 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 119 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 121 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 123 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 124 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 125 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 126 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 127 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 128 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 129 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 131 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 133 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 134 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 136 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 138 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 139 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 141 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 143 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 144 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 146 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 148 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 149 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 150 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 151 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 152 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 153 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 154 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 156 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 158 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 159 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 160 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 161 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 162 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 163 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 164 REST OF ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 REST OF ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 166 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 167 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 169 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 170 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 171 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 172 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 173 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 174 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 175 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 176 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 177 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 179 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 181 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 182 REST OF SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 REST OF SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 184 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 185 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 187 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 188 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 189 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 190 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 191 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 192 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 193 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 194 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 195 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 196 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 197 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 198 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 199 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 200 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 201 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 202 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 204 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 205 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 206 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 207 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 208 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 209 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 210 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 211 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
TABLE 212 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)
TABLE 213 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 214 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 215 REST OF MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 216 REST OF MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)
图片列表
FIGURE 1 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET SHARE ANALYSIS
FIGURE 5 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF ORGAN FAILURE IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET FROM 2024 TO 2034
FIGURE 12 CMV PCR TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET IN 2024 TO 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET AND ASIA-APCIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL DIAGNOSTICS TESTS MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET
FIGURE 16 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2023
FIGURE 17 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2024-2031 (USD THOUSAND)
FIGURE 18 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2024-2031)
FIGURE 19 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE LIFELINE CURVE
FIGURE 20 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2023
FIGURE 21 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 22 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, CAGR (2024-2031)
FIGURE 23 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, LIFELINE CURVE
FIGURE 24 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2023
FIGURE 25 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 26 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: APPLICATION, CAGR (2024-2031)
FIGURE 27 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2023
FIGURE 29 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 30 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, CAGR (2024-2031)
FIGURE 31 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SNAPSHOT (2023)
FIGURE 33 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%)
FIGURE 34 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%)
FIGURE 35 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%)
FIGURE 36 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
